.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Farmers Insurance
Medtronic
McKinsey
AstraZeneca
Healthtrust
McKesson
UBS
Merck

Generated: July 21, 2017

DrugPatentWatch Database Preview

BACTROBAN Drug Profile

« Back to Dashboard

Which patents cover Bactroban, and when can generic versions of Bactroban launch?

Bactroban is a drug marketed by Glaxosmithkline and is included in three NDAs.

The generic ingredient in BACTROBAN is mupirocin. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

Summary for Tradename: BACTROBAN

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list6
Bulk Api Vendors: see list41
Clinical Trials: see list12
Patent Applications: see list3,815
Drug Prices:see details
DailyMed Link:BACTROBAN at DailyMed

Pharmacology for Tradename: BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
BACTROBAN
mupirocin calcium
OINTMENT;NASAL050703-001Sep 18, 1995RXYesYes► Subscribe► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 1997ABRXYesYes► Subscribe► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin
OINTMENT;TOPICAL050591-001Dec 31, 1987DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BACTROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
BACTROBAN
mupirocin calcium
OINTMENT;NASAL050703-001Sep 18, 19955,569,672► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 19976,025,389► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 19975,569,672► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
Citi
Queensland Health
Baxter
Moodys
Dow
Cipla
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot